Dasatinib, sold under the brand name Sprycel among others, is a targeted therapy medication used to treat certain cases of chronic myelogenous leukemia...
22 KB (1,994 words) - 04:41, 3 January 2024
to TK inhibitors, four novel agents were later developed. The first, dasatinib, blocks several further oncogenic proteins, in addition to more potent...
34 KB (3,877 words) - 13:44, 25 October 2024
except for T315I. Dasatinib is also not a substrate of multidrug P-glycoprotein efflux pumps like imatinib. Because of this dasatinib may be active in...
56 KB (6,470 words) - 06:03, 24 October 2024
sofosbuvir, afatinib, axitinib, brigatinib, baricitinib, cabozantinib, dasatinib, neratinib, eltrombopag, ibrutinib, lenvatinib, palbociclib, regorafenib...
5 KB (232 words) - 10:23, 8 March 2024
are repurposed anti-cancer molecules, such as the chemotherapeutic drug dasatinib and the experimental small molecule navitoclax. Soluble urokinase plasminogen...
26 KB (2,028 words) - 10:24, 8 June 2024
kinases) have been developed for therapeutic use. One notable example is dasatinib which has been approved for the treatment of chronic myeloid leukemia...
21 KB (2,648 words) - 12:12, 26 July 2024
are point-mutations in the kinase of BCR-abl. New inhibitors include dasatinib and nilotinib, which are significantly more potent than imatinib and may...
29 KB (3,538 words) - 15:01, 5 December 2023
alefacept, and the tyrosine kinase inhibitors, imatinib, nilotinib, and dasatinib. Experimental therapies under investigation include endothelin receptor...
38 KB (3,293 words) - 18:29, 29 August 2024
Agonists: Ancestim Stem cell factor Kinase inhibitors: Agerafenib Axitinib Dasatinib Imatinib Masitinib Nilotinib Pazopanib Quizartinib Sorafenib Sunitinib...
121 KB (13,799 words) - 18:53, 22 October 2024
D+Q may refer to: Dasatinib#Dasatinib+Quercetin Drawn & Quarterly This disambiguation page lists articles associated with the title D+Q. If an internal...
231 bytes (42 words) - 03:27, 19 December 2023
leukemia (CML) and later gefitinib and erlotinib aiming at the EGF receptor. Dasatinib is a Src tyrosine kinase inhibitor that is effective both as a senolytic...
10 KB (1,179 words) - 18:31, 8 August 2024
symptoms. Among currently available inhibitors to treat CML are imatinib, dasatinib, nilotinib, bosutinib and ponatinib. Gastrointestinal stromal tumors (GIST)...
43 KB (5,251 words) - 10:44, 24 June 2024
2006: FDA Approval of Dasatinib and Nilotinib for Resistant Leukemia MD Anderson researchers demonstrate the efficacy of dasatinib and nilotinib, leading...
54 KB (5,298 words) - 18:20, 16 October 2024
Agonists: Ancestim Stem cell factor Kinase inhibitors: Agerafenib Axitinib Dasatinib Imatinib Masitinib Nilotinib Pazopanib Quizartinib Sorafenib Sunitinib...
92 KB (8,729 words) - 03:44, 26 October 2024
T315I) and some dasatinib resistant mutations. Bafetinib also has more affinity for Bcr-Abl than nilotinib (but less than dasatinib) but only targets...
8 KB (733 words) - 11:36, 12 August 2023
Meclozine MT-45 Oxatomide SNC-80 Vanoxerine Pyrimidinylpiperazines Buspirone Dasatinib Eptapirone Gepirone Ipsapirone Piribedil Pyrimidinylpiperazine Revospirone...
22 KB (1,721 words) - 04:54, 24 October 2024
Meclozine MT-45 Oxatomide SNC-80 Vanoxerine Pyrimidinylpiperazines Buspirone Dasatinib Eptapirone Gepirone Ipsapirone Piribedil Pyrimidinylpiperazine Revospirone...
66 KB (6,684 words) - 02:26, 28 October 2024
Meclozine MT-45 Oxatomide SNC-80 Vanoxerine Pyrimidinylpiperazines Buspirone Dasatinib Eptapirone Gepirone Ipsapirone Piribedil Pyrimidinylpiperazine Revospirone...
83 KB (7,399 words) - 04:12, 27 October 2024
pyrimidinylpiperazine derivatives are drugs, including: Buspirone – anxiolytic Dasatinib – anticancer agent Eptapirone – anxiolytic Gepirone – anxiolytic Ipsapirone –...
7 KB (520 words) - 13:23, 12 March 2024
Agonists: Ancestim Stem cell factor Kinase inhibitors: Agerafenib Axitinib Dasatinib Imatinib Masitinib Nilotinib Pazopanib Quizartinib Sorafenib Sunitinib...
68 KB (5,999 words) - 00:04, 25 October 2024
Asparaginase Cladribine Clofarabine Cyclophosphamide Cytosine arabinoside Dasatinib Daunorubicin Decitabine Etoposide Fludarabine Gemtuzumab ozogamicin Idarubicin...
1 KB (70 words) - 18:51, 14 November 2023
Agonists: Ancestim Stem cell factor Kinase inhibitors: Agerafenib Axitinib Dasatinib Imatinib Masitinib Nilotinib Pazopanib Quizartinib Sorafenib Sunitinib...
149 KB (15,703 words) - 20:22, 18 October 2024
functions to overcome other disease drivers. Kinase inhibitors such as dasatinib are often used in the treatment of cancer and inflammation. Some of the...
23 KB (750 words) - 23:26, 13 August 2024
Agonists: Ancestim Stem cell factor Kinase inhibitors: Agerafenib Axitinib Dasatinib Imatinib Masitinib Nilotinib Pazopanib Quizartinib Sorafenib Sunitinib...
13 KB (1,177 words) - 02:19, 4 September 2024
agents. PP1, PP2 (kinase inhibitor) are both inhibitors of Lck and FynT. Dasatinib Rivera-Torres J, José ES (2019). "Src Tyrosine Kinase Inhibitors: New...
3 KB (332 words) - 14:43, 20 November 2023
Agonists: Ancestim Stem cell factor Kinase inhibitors: Agerafenib Axitinib Dasatinib Imatinib Masitinib Nilotinib Pazopanib Quizartinib Sorafenib Sunitinib...
42 KB (3,935 words) - 20:28, 27 October 2024
replaced gefitinib in this setting. Sorafenib (Nexavar) Sunitinib (Sutent) Dasatinib (Sprycel) Lapatinib (Tykerb) Nilotinib (Tasigna) Bosutinib (Bosulif) Ponatinib...
20 KB (2,234 words) - 01:21, 22 July 2024
Agonists: Ancestim Stem cell factor Kinase inhibitors: Agerafenib Axitinib Dasatinib Imatinib Masitinib Nilotinib Pazopanib Quizartinib Sorafenib Sunitinib...
25 KB (2,086 words) - 02:24, 16 July 2024
Agonists: Ancestim Stem cell factor Kinase inhibitors: Agerafenib Axitinib Dasatinib Imatinib Masitinib Nilotinib Pazopanib Quizartinib Sorafenib Sunitinib...
31 KB (3,428 words) - 18:05, 24 October 2024
of exposure to drugs such as benfluorex (a fenfluramine derivative), dasatinib, cocaine, methamphetamine, ethanol leading to cirrhosis, and tobacco leading...
89 KB (8,895 words) - 04:45, 29 September 2024